[1]SOO KB，SIK TB，HYEON KJ，et al.Rate and association of lower urinary tract infection with recurrence after transurethral resection of bladder tumor［J］.Investigative and Clinical Urology，2018，59(1)：10-17.
[2]KANG GR，SOHN DW，CHUNG DJ.A case of extravesical metastases occurring after transurethral resection of non-invasive bladder cancer［J］.Journal of the Korean Society of Radiology，2018，78(2)：141-144.
[3]LEE J，JEH SU，KOH DH，et al.Probe-based confocal laser endomicroscopy during transurethral resection of bladder tumors improves the diagnostic accuracy and therapeutic efficacy［J］.Ann Surg Oncol，2019，26(4)：1157-1165.
[4]符伟军.膀胱癌患者诊疗指南［M］.北京：人民军医出版社，2014：22-24.
FU WJ.The guidelines of diagnosis and treatment for patients with bladder cancer［M］.Beijing:People' s Military Medical Press，2014：22-24.
[5]KATHERINE A，ALVARO L.Stress urinary incontinence management in the patient with overactive bladder［J］.Current Bladder Dysfunction Reports，2018，13(3)：111-117.
[6]LIAO L，CHUANG YC，LIU SP，et al.Effect of lower urinary tract symptoms on the quality of life and sexual function of males in China，Taiwan，and South Korea：Subgroup analysis of a cross-sectional，population-based study［J］.Luts Lower Urinary Tract Symptoms，2019，11(2)：78-84.
[7]戴涟生，叶俊星，杨晓斐，等.三联药物注射辅助治疗Ⅱ-Ⅲ级老年KOA临床研究［J］.中国医院药学杂志，2018，38(3)：295-297，261.
DAI LS，YE JX，YANG XF，et al.Clinical study of three drug injection therapy combined with arthroscopic debridement in the treatment of elderly patients with grade Ⅱ-Ⅲ knee osteoarthritis［J］.Chinese Journal of Hospital Pharmacy，2018，38(3)：295-297，261.
[8]赵继明，祝筠.膀胱癌患者手术前后生命质量变化及影响因素分析［J］.中华肿瘤防治杂志，2017，24(15)：1030-1034.
ZHAO JM，ZHU Y.Analysis of life quality before and after operation and its influential factors in patients with bladder cancer［J］.Chinese Journal of Cancer Prevention and Treatment，2017，24(15)：1030-1034.
[9]ZAINFELD D，DANESHMAND S.Transurethral resection of bladder tumors：improving quality through new techniques and technologies［J］.Current Urology Reports，2017，18(5)：34.
[10]KIM HS，JEONG CW，KWAK C，et al.Adjuvant chemotherapy for muscle-invasive bladder cancer：a systematic review and network meta-analysis of randomized clinical trials［J］.Oncotarget，2017，8(46)：81204-81214.
[11]PALOU J，PISANO F，SYLVESTER R，et al.Recurrence，progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG：not as bad as previously thought［J］.World Journal of Urology，2018，16(3)：1-7.
[12]VALE CL.Adjuvant chemotherapy for invasive bladder cancer(individual patient data)［J］.Der Urologe，2017，56(2)：237-240.
[13]王志，申凯，廖有刚.经腹膜外改良逆行膀胱全切术＋原位回肠新膀胱术治疗男性浸润性膀胱癌临床观察［J］.医学临床研究，2017，34(9)：1711-1714.
WANG Z，SHEN K，LIAO YG.Clinical analysis of modified radical cystectomy combined with orthotopic ileal neobladder for invasive bladder cancer in male patients［J］.Journal of Clinical Research，2017，34(9)：1711-1714.
[14]GAN Y，HE L，YAO K，et al.Knockdown of HMGN5 increases the chemosensitivity of human urothelial bladder cancer cells to cisplatin by targeting PI3K/Akt signaling［J］.Oncology Letters，2017，14(6)：6463-6470.
[15]ZHUO Y，CHEN Q，CHEN B，et al.Berberine promotes antiproliferative effects of epirubicin in T24 bladder cancer cells by enhancing apoptosis and cell cycle arrest［J］.Int J Clin Pharmacol Ther，2017，55(1)：32-40.
[16]YANSHI X，LIN Y，JUNZUN L，et al.Combination chemotherapy with Zyflamend reduced the acquired resistance of bladder cancer cells to cisplatin through inhibiting NFκB signaling pathway［J］.OncoTargets and Therapy，2018，11(1)：4413-4429.
[17]瓦斯里江?瓦哈甫，刘赛，王梦童，等.膀胱癌根治术前单次动脉灌注化疗的长期疗效评估［J］.首都医科大学学报，2018，39(03)：117-121.
WASILIJIANG?WHF，LIU S，WANG MT，et al.Long-term efficacy of one-shot intra-arterial chemotherapy before radical cystectomy［J］.Journal of Capital Medical University，2018，39(03)：117-121.